Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The selective cardiac myosin activator omecamtiv mecarbil has been shown to improve cardiac function in patients with heart failure with a reduced ejection fraction. Its effect on cardiovascular outcomes is unknown. METHODS: We randomly assigned 8256 patients (inpatients and outpatients) with symptomatic chronic heart failure and an ejection fraction of 35% or less to receive omecamtiv mecarbil (using pharmacokinetic-guided doses of 25 mg, 37.5 mg, or 50 mg twice daily) or placebo, in addition to standard heart-failure therapy. The primary outcome was a composite of a first heart-failure event (hospitalization or urgent visit for heart failure) or death from cardiovascular causes. RESULTS: During a median of 21.8 months, a primary-outcome event occurred in 1523 of 4120 patients (37.0%) in the omecamtiv mecarbil group and in 1607 of 4112 patients (39.1%) in the placebo group (hazard ratio, 0.92; 95% confidence interval [CI], 0.86 to 0.99; P = 0.03). A total of 808 patients (19.6%) and 798 patients (19.4%), respectively, died from cardiovascular causes (hazard ratio, 1.01; 95% CI, 0.92 to 1.11). There was no significant difference between groups in the change from baseline on the Kansas City Cardiomyopathy Questionnaire total symptom score. At week 24, the change from baseline for the median N-terminal pro-B-type natriuretic peptide level was 10% lower in the omecamtiv mecarbil group than in the placebo group; the median cardiac troponin I level was 4 ng per liter higher. The frequency of cardiac ischemic and ventricular arrhythmia events was similar in the two groups. CONCLUSIONS: Among patients with heart failure and a reduced ejection, those who received omecamtiv mecarbil had a lower incidence of a composite of a heart-failure event or death from cardiovascular causes than those who received placebo. (Funded by Amgen and others; GALACTIC-HF ClinicalTrials.gov number, NCT02929329; EudraCT number, 2016-002299-28.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Compared with placebo, OM reduced incidence of the primary outcome over 22 months of follow-up (37.0% vs 39.1%; HR, 0.92 [95% CI 0.85-0.99]).”
From CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction (2021) · cites this paper as [72]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Proportional Hazards Model for the Subdistribution of a Competing Risk
Fine, J. P., & Gray, R. J. (1999) · Journal of the American Statistical Association · doi:10.1080/01621459.1999.10474144 · Cited by 14,290
Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J., & Smith, P. G. (1977) · British Journal of Cancer · doi:10.1038/bjc.1977.1 · Cited by 8,285
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
McMurray, J. J. V., Solomon, S. D., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Anand, I. S., Bělohlávek, J., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1911303 · Cited by 7,140
Self-citationCardiovascular and renal outcomes with empagliflozin in heart failure
Packer, M., Anker, S. D., Butler, J., Filippatos, G., Pocock, S. J., Carson, P., Januzzi, J., Verma, S., Tsutsui, H., Brueckmann, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2022190 · Cited by 5,206
Self-citationRegularization Paths for Cox's Proportional Hazards Model via Coordinate Descent
Simon, N., Friedman, J., Hastie, T., & Tibshirani, R. (2011) · Journal of Statistical Software · doi:10.18637/jss.v039.i05 · Cited by 2,499
Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J., & Smith, P. G. (1976) · British Journal of Cancer · doi:10.1038/bjc.1976.220 · Cited by 2,294
2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials
Hicks, K. A., Mahaffey, K. W., Mehran, R., Nissen, S. E., Wiviott, S. D., Dunn, B., Solomon, S. D., Marler, J. R., Teerlink, J. R., Farb, A., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.033502 · Cited by 750
Self-citationCardiac Myosin Activation: A Potential Therapeutic Approach for Systolic Heart Failure
Malik, F. I., Hartman, J. J., Elias, K. A., Morgan, B. P., Rodriguez, H., Brejc, K., Anderson, R. L., Sueoka, S. H., Lee, K. H., Finer, J. T., et al. (2011) · Science · doi:10.1126/science.1200113 · Cited by 584
Self-citationRepeated assessment of results in clinical trials of cancer treatment
Haybittle, J. L. (1971) · The British Journal of Radiology · doi:10.1259/0007-1285-44-526-793 · Cited by 517
Kramer, D. G., Trikalinos, T. A., Kent, D. M., Antonopoulos, G. V., Konstam, M. A., & Udelson, J. E. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.05.011 · Cited by 492
Cited by
2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab368 · Cited by 13,344
Self-citationAuthors/Task Force Members:, McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., et al. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2333 · Cited by 2,171
Self-citationBozkurt, B., Coats, A. J. S., Tsutsui, H., Abdelhamid, C. M., Adamopoulos, S., Albert, N., Anker, S. D., Atherton, J., Böhm, M., Butler, J., et al. (2021) · European Journal of Heart Failure · doi:10.1002/ejhf.2115 · Cited by 1,665
Self-citationUniversal Definition and Classification of Heart Failure
Bozkurt, B., Coats, A. J., Tsutsui, H., Abdelhamid, M., Adamopoulos, S., Albert, N., Anker, S. D., Atherton, J., Böhm, M., Butler, J., et al. (2021) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2021.01.022 · Cited by 995
Self-citationSex differences in heart failure
Lam, C. S. P., Arnott, C., Beale, A. L., Chandramouli, C., Hilfiker-Kleiner, D., Kaye, D. M., Ky, B., Santema, B. T., Sliwa, K., & Voors, A. A. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz835 · Cited by 802
Self-citationHeart failure with mid-range or mildly reduced ejection fraction
Savarese, G., Stolfo, D., Sinagra, G., & Lund, L. H. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00605-5 · Cited by 476
Tromp, J., Ouwerkerk, W., van Veldhuisen, D. J., Hillege, H. L., Richards, A. M., van der Meer, P., Anand, I. S., Lam, C. S. P., & Voors, A. A. (2022) · JACC: Heart Failure · doi:10.1016/j.jchf.2021.09.004 · Cited by 401
Self-citationWorsening Heart Failure: Nomenclature, Epidemiology, and Future Directions
Greene, S. J., Bauersachs, J., Brugts, J. J., Ezekowitz, J. A., Lam, C. S. P., Lund, L. H., Ponikowski, P., Voors, A. A., Zannad, F., Zieroth, S., et al. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.11.023 · Cited by 303
Self-citationMcDonald, M., Virani, S., Chan, M., Ducharme, A., Ezekowitz, J. A., Giannetti, N., Heckman, G. A., Howlett, J. G., Koshman, S. L., Lepage, S., et al. (2021) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2021.01.017 · Cited by 287
Self-citationAtualização de Tópicos Emergentes da Diretriz Brasileira de Insuficiência Cardíaca – 2021
Marcondes‐Braga, F. G., Moura, L. Z., Issa, V. S., Vieira, J. L., Rohde, L. E. P., Simões, M. V., Fernandes-Silva, M. M., Rassi, S., Martins, S. M., de Albuquerque, D. C., et al. (2021) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20210367 · Cited by 245
Self-citationSpertus, J. A., Fine, J. T., Elliott, P., Ho, C. Y., Olivotto, I., Saberi, S., Li, W., Dolan, C., Reaney, M., Sehnert, A. J., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00763-7 · Cited by 220
Beldhuis, I. E., Lam, C. S. P., Testani, J. M., Voors, A. A., Van Spall, H. G. C., ter Maaten, J. M., & Damman, K. (2022) · Circulation · doi:10.1161/circulationaha.121.052792 · Cited by 216
Self-citationPathophysiology and Therapeutic Approaches to Acute Decompensated Heart Failure
Njoroge, J. N., & Teerlink, J. R. (2021) · Circulation Research · doi:10.1161/circresaha.121.318186 · Cited by 214
Self-citationMcDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2022) · Giornale Italiano di Cardiologia · doi:10.1714/3777.37630 · Cited by 196
Self-citationJCS/JHFS 2021 Guideline Focused Update on Diagnosis and Treatment of Acute and Chronic Heart Failure
Tsutsui, H., Ide, T., Ito, H., Kihara, Y., Kinugawa, K., Kinugawa, S., Makaya, M., Murohara, T., Node, K., Saito, Y., et al. (2021) · Circulation Journal · doi:10.1253/circj.cj-21-0431 · Cited by 183
Self-citationBanking research in the time of COVID-19
Berger, A. N., & Demirgüç‐Kunt, A. (2021) · Journal of Financial Stability · doi:10.1016/j.jfs.2021.100939 · Cited by 182
Sex Differences in Heart Failure
Lala, A., TAYAL, U., HAMO, C. E., YOUMANS, Q., AL-KHATIB, S. M., BOZKURT, B., DAVIS, M. B., JANUZZI, J., MENTZ, R., SAUER, A., et al. (2022) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2021.10.006 · Cited by 179
Guía ESC 2021 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O. D., et al. (2022) · Revista Española de Cardiología · doi:10.1016/j.recesp.2021.11.027 · Cited by 177
Self-citationMüllens, W., Martens, P., Testani, J. M., Tang, W. H. W., Skouri, H. N., Verbrugge, F. H., Fudim, M., Iacoviello, M., Franke, J., Flammer, A. J., et al. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2471 · Cited by 164
Self-citationPacker, M., & McMurray, J. J. V. (2021) · European Journal of Heart Failure · doi:10.1002/ejhf.2149 · Cited by 160
Self-citationKhan, M. S., Shahid, I., Anker, S. D., Fonarow, G. C., Fudim, M., Hall, M. E., Hernandez, A. F., Morris, A. A., Shafi, T., Weir, M. R., et al. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.10.028 · Cited by 160
Self-citation2026 ESC Guidelines for the management of heart failure
Køber, L., Adamo, M., Ruwald, A., Tomasoni, D., Anderson, L., Andersson, C., Brugts, J. J., Chioncel, O. D., Donal, E., Ferdinandy, P., et al. (2026) · European Heart Journal · doi:10.1093/eurheartj/ehag100 · Cited by 159
JCS/JHFS 2021 Guideline Focused Update on Diagnosis and Treatment of Acute and Chronic Heart Failure
Tsutsui, H., Ide, T., Ito, H., Kihara, Y., Kinugawa, K., Kinugawa, S., Makaya, M., Murohara, T., Node, K., Saito, Y., et al. (2021) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2021.04.023 · Cited by 158
Self-citationCurrent and future therapeutic perspective in chronic heart failure
Mascolo, A., di Mauro, G., Cappetta, D., Angelis, A. D., Torella, D., Urbanek, K., Berrino, L., Nicoletti, G. F., Capuano, A., & Rossi, F. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.106035 · Cited by 150
Diabetic cardiomyopathy: Clinical phenotype and practice
Zhao, X., Liu, S., Wang, X., Chen, Y., Pang, P., Yang, Q., Lin, J., Deng, S., Shen-tao, W., Fan, G., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1032268 · Cited by 133
Targeting the sarcomere in inherited cardiomyopathies
Lehman, S. J., Crocini, C., & Leinwand, L. A. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00682-0 · Cited by 128
Felker, G. M., Solomon, S. D., Claggett, B. L., Díaz, R., McMurray, J. J. V., Metra, M., Anand, I. S., Crespo-Leiro, M. G., Dahlström, U., Gonçalvesová, E., et al. (2021) · JAMA Cardiology · doi:10.1001/jamacardio.2021.4027 · Cited by 126
Self-citationBogle, C., Colan, S. D., Miyamoto, S. D., Choudhry, S., Hernandez, N. B., Brickler, M. M., Feingold, B., Lal, A. K., Lee, T. M., Canter, C. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001151 · Cited by 125
Butler, J., McMullan, C. J., Anstrom, K. J., Barash, I., Bonaca, M. P., Borentain, M., Corda, S., Ezekowitz, J. A., Felker, G. M., Gates, D. F., et al. (2025) · The Lancet · doi:10.1016/s0140-6736(25)01665-4 · Cited by 121
Self-citationSGLT2 Inhibitors and Ketone Metabolism in Heart Failure
Saucedo‐Orozco, H., Voorrips, S. N., Yurista, S. R., de Boer, R. A., & Westenbrink, B. D. (2022) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2022.11.1.1 · Cited by 114
Teerlink, J. R., Díaz, R., Felker, G. M., McMurray, J. J. V., Metra, M., Solomon, S. D., Biering‐Sørensen, T., Böhm, M., Bonderman, D., Fang, J. C., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.04.065 · Cited by 111
Self-citationPathophysiology of dilated cardiomyopathy: from mechanisms to precision medicine
Gigli, M., Stolfo, D., Merlo, M., Sinagra, G., Taylor, M. R. G., & Mestroni, L. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-024-01074-2 · Cited by 109
MARK4 controls ischaemic heart failure through microtubule detyrosination
Yu, X., Chen, X., Amrute-Nayak, M., Allgeyer, E., Zhao, A., Chenoweth, H., Clement, M., Harrison, J., Doreth, C., Sirinakis, G., et al. (2021) · Nature · doi:10.1038/s41586-021-03573-5 · Cited by 105
Inciardi, R. M., Bonelli, A., Biering‐Sørensen, T., Cameli, M., Pagnesi, M., Lombardi, C., Solomon, S. D., & Metra, M. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2562 · Cited by 101
Self-citationThe significance of left ventricular ejection time in heart failure with reduced ejection fraction
Alhakak, A. S., Teerlink, J. R., Lindenfeld, J. M., Böhm, M., Rosano, G. M. C., & Biering‐Sørensen, T. (2021) · European Journal of Heart Failure · doi:10.1002/ejhf.2125 · Cited by 100
Self-citationHeart Failure in the Last Year: Progress and Perspective
Tomasoni, D., Adamo, M., Anker, M. S., von Haehling, S., Coats, A. J. S., & Metra, M. (2020) · ESC Heart Failure · doi:10.1002/ehf2.13124 · Cited by 100
Self-citationTromp, J., Ponikowski, P., Salsali, A., Angermann, C. E., Biegus, J., Blatchford, J., Collins, S. P., Ferreira, J. P., Grauer, C., Kosiborod, M., et al. (2021) · European Journal of Heart Failure · doi:10.1002/ejhf.2137 · Cited by 99
Self-citationArrhythmias as Presentation of Genetic Cardiomyopathy
Laws, J. L., Lancaster, M. C., Shoemaker, M. B., Stevenson, W. G., Hung, R. R., Wells, Q. S., Brinkley, D. M., Hughes, S. G., Anderson, K. C., Roden, D. M., et al. (2022) · Circulation Research · doi:10.1161/circresaha.122.319835 · Cited by 99
Wang, S. Y., Elizondo, J. V., Ali, H., Pandey, A., Cainzos‐Achirica, M., Krumholz, H. M., Nasir, K., & Khera, R. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.121.022164 · Cited by 98
Tomasoni, D., Vishram‐Nielsen, J. K. K., Pagnesi, M., Adamo, M., Lombardi, C., Gustafsson, F., & Metra, M. (2022) · ESC Heart Failure · doi:10.1002/ehf2.13859 · Cited by 97
Self-citationImplications of Atrial Fibrillation for Guideline-Directed Therapy in Patients With Heart Failure
Newman, J. D., O’Meara, E., Böhm, M., Savarese, G., Kelly, P. R., Vardeny, O., Allen, L. A., Lancellotti, P., Gottlieb, S. S., Samad, Z. Z., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.12.033 · Cited by 96
Self-citationCardiac sarcomere mechanics in health and disease
Crocini, C., & Gotthardt, M. (2021) · Biophysical Reviews · doi:10.1007/s12551-021-00840-7 · Cited by 94
Schmid, M., & Toepfer, C. N. (2021) · Biology Open · doi:10.1242/bio.057646 · Cited by 93
Cardiac myosin contraction and mechanotransduction in health and disease
Barrick, S. K., & Greenberg, M. J. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101297 · Cited by 92
Butt, J. H., Docherty, K. F., Jhund, P. S., de Boer, R. A., Böhm, M., Desai, A. S., Howlett, J. G., Inzucchi, S. E., Kosiborod, M., Martínez, F. A., et al. (2021) · European Journal of Heart Failure · doi:10.1002/ejhf.2381 · Cited by 90
Self-citationGuideline-Directed Medical Therapy for the Treatment of Heart Failure with Reduced Ejection Fraction
Patel, J., Rassekh, N., Fonarow, G. C., DEEDWANIA, P. C., Sheikh, F. H., Ahmed, A., & Lam, P. H. (2023) · Drugs · doi:10.1007/s40265-023-01887-4 · Cited by 89
Towards precision medicine in heart failure
Weldy, C. S., & Ashley, E. A. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00566-9 · Cited by 89
Genetics of Dilated Cardiomyopathy
Eldemire, R., Mestroni, L., & Taylor, M. R. G. (2023) · Annual Review of Medicine · doi:10.1146/annurev-med-052422-020535 · Cited by 87
Genetic architecture of heart failure with preserved versus reduced ejection fraction
Joseph, J., Liu, C., Hui, Q., Aragam, K. G., Wang, Z., CHAREST, B. R., Huffman, J. E., Keaton, J. M., Edwards, T. L., Demissie, S., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-35323-0 · Cited by 86
Mechanisms and Models in Heart Failure: A Translational Approach
Mann, D. L., & Felker, G. M. (2021) · Circulation Research · doi:10.1161/circresaha.121.318158 · Cited by 84
Self-citationMitochondrial dysfunction in heart failure and its therapeutic implications
Liu, M., Lv, J., Pan, Z., Wang, D., Zhao, L., & Guo, X. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.945142 · Cited by 83
Myosin modulators: emerging approaches for the treatment of cardiomyopathies and heart failure
Day, S. M., Tardiff, J. C., & Ostap, E. M. (2022) · Journal of Clinical Investigation · doi:10.1172/jci148557 · Cited by 83
Heart Failure: An Update from the Last Years and a Look at the Near Future
Riccardi, M., Sammartino, A. M., Piepoli, M. F., Adamo, M., Pagnesi, M., Rosano, G. M. C., Metra, M., von Haehling, S., & Tomasoni, D. (2022) · ESC Heart Failure · doi:10.1002/ehf2.14257 · Cited by 81
Self-citationUse of Patient-Reported Outcomes in Heart Failure: From Clinical Trials to Routine Practice
Savarese, G., Lindenfeld, J. M., Stolfo, D., Adams, K. F., Ahmad, T., Desai, N. R., Ammirati, E., Gottlieb, S. S., Psotka, M. A., Rosano, G. M. C., et al. (2023) · European Journal of Heart Failure · doi:10.1002/ejhf.2778 · Cited by 76
Self-citationLewis, G. D., Voors, A. A., Solal, A. C., Metra, M., Whellan, D. J., Ezekowitz, J. A., Böhm, M., Teerlink, J. R., Docherty, K. F., Lópes, R. D., et al. (2022) · JAMA · doi:10.1001/jama.2022.11016 · Cited by 76
Self-citationDiuretic Treatment in Heart Failure: A Practical Guide for Clinicians
Wu, L., Rodríguez, M., Hachem, K. E., & Krittanawong, C. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13154470 · Cited by 74
Gustafsson, F., Damman, K., Nalbantgil, S., Laake, L. W. V., Tops, L. F., Thum, T., Adamopoulos, S. N., Bonios, M. J., Coats, A. J. S., Crespo-Leiro, M. G., et al. (2023) · European Journal of Heart Failure · doi:10.1002/ejhf.2814 · Cited by 74
Self-citationCurrent and emerging drug targets in heart failure treatment
Ghionzoli, N., Gentile, F., Franco, A. D., Castiglione, V., Aimo, A., Giannoni, A., Burchielli, S., Cameli, M., Emdin, M., & Vergaro, G. (2021) · Heart Failure Reviews · doi:10.1007/s10741-021-10137-2 · Cited by 72
Translation of New and Emerging Therapies for Genetic Cardiomyopathies
Helms, A. S., Thompson, A. D., & Day, S. M. (2021) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2021.07.012 · Cited by 72
Management of Worsening Heart Failure With Reduced Ejection Fraction
Greene, S. J., Bauersachs, J. K., Brugts, J. J., Ezekowitz, J. A., Filippatos, G. S., Gustafsson, F., Lam, C. S. P., Lund, L. H., Mentz, R. J., Pieske, B. M., et al. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.04.057 · Cited by 62
Self-citationHypertrophic cardiomyopathy: Mutations to mechanisms to therapies
Kawana, M., Spudich, J. A., & Ruppel, K. M. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.975076 · Cited by 62
Recent Findings Related to Cardiomyopathy and Genetics
Yamada, T., & Nomura, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212522 · Cited by 62
DeFilippis, E. M., Echols, M. R., Adamson, P. B., Batchelor, W., Cooper, L. B., Cooper, L. S., Desvigne-Nickens, P. M., George, R. T., Ibrahim, N. E., Jessup, M. L., et al. (2022) · JAMA Cardiology · doi:10.1001/jamacardio.2022.0161 · Cited by 61
Self-citationButt, J. H., Adamson, C., Docherty, K. F., de Boer, R. A., Petrie, M. C., Inzucchi, S. E., Kosiborod, M. N., Langkilde, A. M., Lindholm, D. P., Martinez, F. A., et al. (2021) · Circulation Heart Failure · doi:10.1161/circheartfailure.121.008837 · Cited by 61
Self-citationCao, W. F., Qiao, S., Zhao, Y., Tian, H., Yan, W., Hou, X., Wang, R. L., Zhang, B., Yang, C., Zhu, F., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36712-9 · Cited by 61
Mechano-energetic uncoupling in heart failure
Aksentijević, D., Sedej, S., Fauconnier, J., Paillard, M., Abdellatif, M., Streckfuß‐Bömeke, K., Ventura‐Clapier, R., van der Velden, J., de Boer, R. A., Bertero, E., et al. (2025) · Nature Reviews Cardiology · doi:10.1038/s41569-025-01167-6 · Cited by 60
Skouri, H. N., Girerd, N., Monzo, L., Petrie, M. C., Böhm, M., Adamo, M., Müllens, W., Savarese, G., Yılmaz, M. B., Amir, O., et al. (2025) · European Journal of Heart Failure · doi:10.1002/ejhf.3618 · Cited by 60
Self-citationBayés‐Genís, A., Aimo, A., Jhund, P. S., Richards, M., de Boer, R. A., Arfsten, H., Fabiani, I., Lupón, J., Anker, S. D., González, A., et al. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2675 · Cited by 58
Self-citationSex and Gender Bias as a Mechanistic Determinant of Cardiovascular Disease Outcomes
Kim, I., Field, T. S., Wan, D., Humphries, K. H., & Sedlak, T. (2022) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2022.09.009 · Cited by 57
A Novel Approach to Medical Management of Heart Failure With Reduced Ejection Fraction
Miller, R. J. H., Howlett, J. G., & Fine, N. M. (2021) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2020.12.028 · Cited by 57
Self-citationYang, J., Grafton, F., Ranjbarvaziri, S., Budan, A., Farshidfar, F., Cho, M., Xu, E., Ho, J. J., Maddah, M., Loewke, K. E., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abl5654 · Cited by 57
Small Molecules Acting on Myofilaments as Treatments for Heart and Skeletal Muscle Diseases
Alsulami, K. A., & Marston, S. B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249599 · Cited by 56
Drug Layering in Heart Failure
Rosano, G. M. C., Allen, L. A., Abdin, A., Lindenfeld, J. M., O’Meara, E., Lam, C. S. P., Lancellotti, P., Savarese, G., Gottlieb, S. S., Teerlink, J. R., et al. (2021) · JACC Heart Failure · doi:10.1016/j.jchf.2021.06.011 · Cited by 55
Self-citationRosano, G. M. C., Vitale, C., Adamo, M., & Metra, M. (2021) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000001221 · Cited by 55
Self-citationHulot, J., Trochu, J., Donal, E., Galinier, M., Logeart, D., de Groote, P., & Juillière, Y. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1937121 · Cited by 54
Auguin, D., Robert‐Paganin, J., Réty, S., Kikuti, C. M., David, A., Theumer, G., Schmidt, A. W., Knölker, H., & Houdusse, A. (2024) · Nature Communications · doi:10.1038/s41467-024-47587-9 · Cited by 54
Masri, A., & Olivotto, I. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.024656 · Cited by 54
Molecular Mechanisms Underlying Heart Failure and Their Therapeutic Potential
Fonseka, O., Gare, S. R., Chen, X., Zhang, J., Alatawi, N. H. O., Ross, C., & Liu, W. (2025) · Cells · doi:10.3390/cells14050324 · Cited by 53
A Year in Heart Failure: An Update of Recent Findings
Stretti, L., Zippo, D., Coats, A. J. S., Anker, M. S., von Haehling, S., Metra, M., & Tomasoni, D. (2021) · ESC Heart Failure · doi:10.1002/ehf2.13760 · Cited by 52
Self-citationVericiguat Global Study in Participants with Chronic Heart Failure: Design of the VICTOR Trial
Reddy, Y. N. V., Butler, J., Anstrom, K. J., Blaustein, R. O., Bonaca, M. P., Corda, S., Ezekowitz, J. A., Lam, C. S. P., Lewis, E. F., Lindenfeld, J., et al. (2024) · European Journal of Heart Failure · doi:10.1002/ejhf.3501 · Cited by 52
Self-citationBrain Natriuretic Peptide Biomarkers in Current Clinical and Therapeutic Scenarios of Heart Failure
Alcidi, G., Goffredo, G., Correale, M., Brunetti, N. D., & Iacoviello, M. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11113192 · Cited by 51
Current status on the therapeutic strategies for heart failure and diabetic cardiomyopathy
Kim, A. H., Jang, J. E., & Han, J. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112463 · Cited by 51
Packer, M., Januzzi, J. L., Ferreira, J. P., Anker, S. D., Butler, J., Filippatos, G. S., Pocock, S., Brueckmann, M., Jamal, W., Cotton, D., et al. (2021) · European Journal of Heart Failure · doi:10.1002/ejhf.2256 · Cited by 50
Self-citationRosano, G. M. C., Stolfo, D., Anderson, L., Abdelhamid, M., Adamo, M., Bauersachs, J., Bayés‐Genís, A., Böhm, M., Chioncel, O. D., Filippatos, G. S., et al. (2024) · European Journal of Heart Failure · doi:10.1002/ejhf.3284 · Cited by 50
Self-citationConsensus statement on the current pharmacological prevention and management of heart failure
Sindone, A. P., Pasquale, C. G. D., Amerena, J. V., Burdeniuk, C., Chan, A., Coats, A. J. S., Hare, D. L., Macdonald, P. S., Sverdlov, A. L., & Atherton, J. J. (2022) · The Medical Journal of Australia · doi:10.5694/mja2.51656 · Cited by 48
Self-citationAnfinson, M. Q., Fitts, R. H., Lough, J., James, J. M., Simpson, P. M., Handler, S. S., Mitchell, M. E., & Tomita‐Mitchell, A. (2022) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd9050144 · Cited by 48
Vericiguat for Heart Failure with Reduced Ejection Fraction
Lombardi, C., Cimino, G., Pagnesi, M., Dell’Aquila, A., Tomasoni, D., Ravera, A., Inciardi, R. M., Carubelli, V., Vizzardi, E., Nodari, S., et al. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01580-6 · Cited by 47
Vaduganathan, M., Cunningham, J. W., Claggett, B. L., Causland, F. M., Barkoudah, E., Finn, P. V., Zannad, F. M., Pfeffer, M. A., Rizkala, A. R., Sabarwal, S. V., et al. (2021) · JACC Heart Failure · doi:10.1016/j.jchf.2021.01.014 · Cited by 47
Self-citationRecent advances in the pharmacological therapy of chronic heart failure: Evidence and guidelines
Tsutsui, H. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108185 · Cited by 47
Genetic Insights into Primary Restrictive Cardiomyopathy
Brodehl, A., & Gerull, B. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11082094 · Cited by 47
Unequitable Heart Failure Therapy for Black, Hispanic and American-Indian Patients
Ilonze, O. J., Free, K., & Breathett, K. K. (2022) · Cardiac failure review · doi:10.15420/cfr.2022.02 · Cited by 46
Greene, S. J., Tan, X., Yeh, Y., Bernauer, M. J., Zaidi, O., Yang, M., & Butler, J. (2021) · Heart Failure Reviews · doi:10.1007/s10741-021-10077-x · Cited by 46
Lund, L. H., Hage, C., Pironti, G., Thorvaldsen, T., Faxén, U. L., Zabarovskaja, S., Shahgaldi, K., Webb, D., Hellström, P. M., Andersson, D. C., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad100 · Cited by 46
Lavalle, C., Mariani, M. V., Severino, P., Palombi, M., Trivigno, S., D’Amato, A., Silvetti, G., Pierucci, N., Lullo, L. D., Chimenti, C., et al. (2024) · Cardiorenal Medicine · doi:10.1159/000541393 · Cited by 45
Danicamtiv Increases Myosin Recruitment and Alters Cross-Bridge Cycling in Cardiac Muscle
Kooiker, K. B., Mohran, S. E., Turner, K. L., Ma, W., Flint, G., Flint, G. V., Gao, C., Zheng, Y., McMillen, T. S., Mandrycky, C., et al. (2023) · Circulation Research · doi:10.1161/circresaha.123.322629 · Cited by 45
The right ventricle in tetralogy of Fallot: adaptation to sequential loading
Symakani, R. S. A., van Genuchten, W. J., Zandbergen, L. M., Henry, S., Taverne, Y. J. H. J., Merkus, D., Helbing, W. A., & Bartelds, B. (2023) · Frontiers in Pediatrics · doi:10.3389/fped.2023.1098248 · Cited by 44
The year in cardiovascular medicine 2020: heart failure and cardiomyopathies
Bueno, H., Moura, B., Lancellotti, P., & Bauersachs, J. K. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa1061 · Cited by 44
Simultaneous electromechanical monitoring in engineered heart tissues using a mesoscale framework
Fullenkamp, D. E., Maeng, W., Oh, S., Luan, H., Kim, K. S., Chychula, I. A., Kim, J., Yoo, J., Holgren, C. W., Demonbreun, A. R., et al. (2024) · Science Advances · doi:10.1126/sciadv.ado7089 · Cited by 44
Ueda, T., Kasama, S., Yamamoto, M., Nakano, T., Ueshima, K., Morikawa, Y., Kawata, H., Yoshihisa, A., Nakayama, M., Komatsu, S., et al. (2021) · Circulation Reports · doi:10.1253/circrep.cr-21-0030 · Cited by 44
Heart failure with reduced ejection fraction
Cannata, A. N., Crespo-Leiro, M. G., Bromage, D. I., Ruschitzka, F., & McDonagh, T. A. (2025) · The Lancet · doi:10.1016/s0140-6736(25)01851-3 · Cited by 44
Self-citation
Metadata
- Authors
- Teerlink, J. R., Diaz, R., Felker, G. M., McMurray, J. J. V., Metra, M., Solomon, S. D., Adams, K. F., Anand, I., Arias-Mendoza, A., Biering-Sørensen, T., Böhm, M., Bonderman, D., Cleland, J. G. F., Corbalan, R., Crespo-Leiro, M. G., Dahlström, U., Echeverria, L. E., Fang, J. C., Filippatos, G., Fonseca, C., Goncalvesova, E., Goudev, A. R., Howlett, J. G., Lanfear, D. E., Li, J., Lund, M., Macdonald, P., Mareev, V., Momomura, S.-I., O’Meara, E., Parkhomenko, A., Ponikowski, P., Ramires, F. J. A., Serpytis, P., Sliwa, K., Spinar, J., Suter, T. M., Tomcsanyi, J., Vandekerckhove, H., Vinereanu, D., Voors, A. A., Yilmaz, M. B., Zannad, F., Sharpsten, L., Legg, J. C., Varin, C., Honarpour, N., Abbasi, S. A., Malik, F. I., & Kurtz, C. E.
- Affiliations
- San Francisco VA Medical Center (US)
- From the Section of Cardiology, San Francisco Veterans Affairs Medical Center and School of Medicine, University of California, San Francisco, San Francisco (J.R.T.), Amgen, Thousand Oaks (L.S., J.C.L., N.H., S.A.A., C.E.K.), and Cytokinetics, South San Francisco (F.I.M.) — all in California; Estudios Clínicos Latino América, Rosario, Argentina (R.D.); the Division of Cardiology, Duke University School of Medicine and Duke Clinical Research Institute, Durham (G.M.F.), and the University of North...
- Brigham and Women's Hospital (US)
- University of North Carolina at Chapel Hill (US)
- University of Minnesota (US)
- Linköping University (SE)
- University of Bern (CH)
- ORCID
- Teerlink, John R.
- Felker, G. Michael
- McMurray, John J.V.
- Metra, Marco
- Solomon, Scott D.
- Anand, Inder
- Böhm, Michael
- Bonderman, Diana
- Cleland, John G.F.
- Dahlström, Ulf
- Fang, James C.
- Filippatos, Gerasimos
- Fonseca, Cândida
- Goudev, Assen R.
- Howlett, Jonathan G.
- Lanfear, David E.
- Li, Jing
- Lund, Mayanna
- Macdonald, Peter
- Momomura, Shin-ichi
- O’Meara, Eileen
- Parkhomenko, Alexander
- Ponikowski, Piotr
- Sliwa, Karen
- Voors, Adriaan A.
- Zannad, Faiez
- Abbasi, Siddique A.
- Malik, Fady I.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2021-01-14
- Volume
- 384
- Issue
- 2
- Pages
- 105-116
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W3098430919
- Cited by
- 656
- References
- 26
- Citations by year
- 2026: 51 · 2025: 84 · 2024: 76 · 2023: 150 · 2022: 130 · 2021: 148
- FWCI
- 68.17
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- New England Journal of Medicine (publishedVersion, other-oa)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion, cc-by-sa)
- HAL (submittedVersion, other-oa)
- BOA (University of Milano-Bicocca) (submittedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion)
- Institutional Research Information System (Università degli Studi di Brescia) (submittedVersion)
- Archive of Doctoral Theses and Digital Collections (University of Calabria) (submittedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- ORBi (University of Liège) (submittedVersion, other-oa)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
- RUC (Universidade Da Coruña) (submittedVersion)
- Funders
- Amgen
- Cytokinetics Inc.
- Servier
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- omecamtiv mecarbil, cardiac myosin activator, heart failure with reduced ejection fraction, cardiovascular outcomes, heart failure hospitalization, cardiovascular mortality, N-terminal pro-brain natriuretic peptide, cardiac troponin I, symptom burden, pharmacokinetic-guided dosing, ventricular arrhythmias
- MeSH terms
- Aged, Aged, 80 and over, Cardiotonic Agents, Cardiovascular Diseases, Female, Humans, Male, Middle Aged, Myocardial Contraction, Stroke Volume, Urea, Cardiac Myosins, Heart Failure, Systolic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.